Compare Hetzer Medical Indonesia Tbk. (MEDS) vs Trimegah Karya Pratama Tbk. (UVCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hetzer Medical Indonesia Tbk. vs Trimegah Karya Pratama Tbk. — how do they compare? Hetzer Medical Indonesia Tbk. trades at Rp86 (market cap 139.06B, 51.66M 24h volume), while Trimegah Karya Pratama Tbk. trades at Rp155 (market cap 314.02B, 49.33M 24h volume). The key difference: Trimegah Karya Pratama Tbk. is far larger — about 2.3× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (51.66M versus 49.33M). Which is the better fit depends on your goals.
| MEDS | UVCR | |
|---|---|---|
Market Cap | 139.06B | 314.02B |
Volume | 51.66M | 49.33M |
Lot | 516.62K | 493.25K |
Turnover | 4.44B | 7.55B |
Average Price | 85.97 | 153.12 |
Value | 4.44B | 7.55B |
Indicative Equilibrium Price | 86 | 155 |
Indicative Equilibrium Volume | 9.62K | 3.77K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hetzer Medical Indonesia Tbk.
PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →About Trimegah Karya Pratama Tbk.
PT Trimegah Karya Pratama Tbk (the Company) was established based on Notarial Deed No. 21 dated July 7, 2017 of Netty Maria Machdar, S.H. The Company started its commercial operations in 2018. The Company’s immediate parent company is PT Trimegah Sumber Mas, which was established and domiciled in Indonesia, while its ultimate Parent Company is PT Hutama Mulia Rajawali, which was established and domiciled in Indonesia.
Read more on UVCR →
